Plain-English translation of NCT05156398 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing , a new medication designed to help prevent migraines in children and teenagers. Researchers want to see if this medication can reduce how often young people get migraines and how much migraines interfere with their daily lives. The medication comes as a small tablet that dissolves on the tongue.
Many children and teens suffer from frequent migraines that can interfere with school, sports, and friendships. While some migraine prevention treatments exist, researchers are looking for new options that work well and are safe for younger patients.
You likely qualify if…
You likely don't qualify if…
You would take a small daily tablet (the medication or placebo) at home for several months. You'll have visits with the research team where they check how you're doing, ask about your migraines, and make sure the medication is safe for you. Some participants will receive the new medication, while others will receive a placebo (a tablet with no medicine) to compare how well the treatment works.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
United States